Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2016 Nov;80(5):702-709.
doi: 10.1038/pr.2016.130. Epub 2016 Jun 21.

Altered Treg and cytokine responses in RSV-infected infants

Affiliations

Altered Treg and cytokine responses in RSV-infected infants

Allison F Christiaansen et al. Pediatr Res. 2016 Nov.

Abstract

Background: Respiratory syncytial virus (RSV) is the leading cause of bronchiolitis and pneumonia in children under 1 y of age in the USA. The host immune response is believed to contribute to RSV-induced disease. We hypothesize that severe RSV infection in infants is mediated by insufficient regulation of the host immune response of regulatory T cells (Tregs) resulting in immunopathology.

Methods: Blood and nasal aspirates from 23 RSV-infected and 17 control infants under 1 y of age were collected. Treg frequencies were determined by flow cytometry from peripheral blood mononuclear cells. Analysis of 24 cytokines was measured by multiplex assay on nasal aspirates.

Results: We demonstrate that the frequency of activated Tregs is significantly reduced in the peripheral blood of RSV-infected infants compared with age-matched controls. Surprisingly, T helper (Th)17 related cytokines including interleukin (IL)-1β, IL-17A, and IL-23 were associated with a reduction in clinical symptoms of respiratory distress. In addition, the amount of IL-33 protein in nasal washes, a cytokine important in maintaining Treg homeostasis in mucosal tissues, was decreased in RSV-infected children.

Conclusion: These results suggest that decreased Treg numbers and an inability to properly control the host inflammatory response results in severe RSV infection.

PubMed Disclaimer

Conflict of interest statement

The authors would like to note that there are no conflicts of interest to declare.

Figures

Figure 1.
Figure 1.. aTreg frequencies are reduced in the peripheral blood of RSV-infected infants.
PBMCs from RSV-infected infants and controls were stained to identify subsets of conventional and regulatory CD4 T cells. (A) Representative plots depict CD45RAhiFoxp3int/CD25int resting Tregs (rTreg, I), CD45RAloFoxp3hi/CD25hi activated Tregs (aTreg, II), CD45RAhiFoxp3- naïve conventional CD4 T cells (III), and CD45RAloFoxp3- memory conventional CD4 T cells (IV) from control and RSV-infected infants. The cumulative frequencies of resting (B) and activated (C) Tregs are shown for controls and RSV-infected infants by two staining methods. (D) Naïve and (E) memory conventional CD4 T cell frequencies are shown from all groups. (F) Ki-67 expression from each CD4 T cell subset defined by CD45RA and Foxp3 expression is shown for both control (white bars) and RSV-infected infants (black bars). All samples are gated on CD4+CD3+ T cells. Data represents the mean ± SEM for both controls (n = 13) and RSV (n = 17) groups. **, p < 0.01.
Figure 2.
Figure 2.. rTreg frequencies decrease as RSV disease progresses.
The coefficients of determination between CD45RAhiFoxp3int rTregs (A, R2 = 0.3569) or CD45RAloFoxp3hi aTregs (B, R2 = 0.0089) and onset of symptoms in RSV-infected infants were calculated along with the p-values measuring significance of association (A, p = 0.0113; B, p = 0.7187).
Figure 3.
Figure 3.. Th17-associated cytokines correlate with reduced difficulty breathing and retraction.
Physical exam findings of difficulty breathing (left) and retraction (right) are associated with Th17-associated but not Th1- or Th2-associated cytokine concentrations in nasal excretions from RSV-infected infants. Data represent the mean ± SEM for both controls (n = 13) and RSV (n = 17) groups. *, p < 0.05. **, p < 0.01.

References

    1. Nair H, Nokes DJ, Gessner BD, et al. Global burden of acute lower respiratory infections due to respiratory syncytial virus in young children: a systematic review and meta-analysis. Lancet 2010;375:1545–1555. - PMC - PubMed
    1. Glezen WP, Taber LH, Frank AL, Kasel JA Risk of primary infection and reinfection with respiratory syncytial virus. Am J Dis Child 1986;140:543–546. - PubMed
    1. García CG, Bhore R, Soriano-Fallas A, et al. Risk factors in children hospitalized with RSV bronchiolitis versus non–RSV bronchiolitis. Pediatrics 2010;126:e1453–e1460. - PMC - PubMed
    1. Rivera CA, Gomez RS, Diaz RA, et al. Novel therapies and vaccines against the human respiratory syncytial virus. Expert Opin Investig Drugs 2015:1–18. - PubMed
    1. Johnson S, Oliver C, Prince GA, et al. Development of a humanized monoclonal antibody (MEDI-493) with potent in vitro and in vivo activity against respiratory syncytial virus. J Infect Dis 1997;176:1215–1224. - PubMed

Publication types

MeSH terms